<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02129426</url>
  </required_header>
  <id_info>
    <org_study_id>Ket-Dex/M-Dex MRI</org_study_id>
    <nct_id>NCT02129426</nct_id>
  </id_info>
  <brief_title>Comparison of Outcomes During MRI Sedation With Midazolam-dexmedetomidine Versus Ketamine-dexmedetomidine</brief_title>
  <official_title>Comparison of Outcomes During MRI Sedation With Midazolam-dexmedetomidine Versus Ketamine-dexmedetomidine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare 2 different sedation drugs (Ketamine and Midazolam) when they are&#xD;
      used with another sedating medicine called Dexmedetomidine for MRI sedation. This study hopes&#xD;
      to measure the impact each drug has on what happens during and after MRI sedation with&#xD;
      Dexmedetomidine&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The will be a randomized, double-blind, prospective study. All patients referred to UCSS for&#xD;
      brain MRI and for whom dexmedetomidine would otherwise be the sedation regimen of choice will&#xD;
      be eligible for enrollment. The investigators propose to limit the study to patients&#xD;
      undergoing only brain MRI as these studies are of a predictable length (25-30 minutes);&#xD;
      therefore the sedation regimen can be more easily standardized. Parents of eligible patients&#xD;
      would be approached prior to or during the pre-sedation assessment and told about the study&#xD;
      and, if they agree to enroll, informed consent would be obtained. Assent will be obtained&#xD;
      from children 7 years of age and greater, if they are otherwise developmentally capable of&#xD;
      giving assent. The goal is to enroll 50 subjects (25 per treatment group) which would be&#xD;
      sufficient to detect a 25% or greater difference in the mean maximal heart rate or blood&#xD;
      pressure decrease from baseline between the 2 groups.&#xD;
&#xD;
      Following consent, subjects would be randomized to be sedated with either&#xD;
      midazolam-dexmedetomidine or ketamine-dexmedetomidine and, upon achieving an appropriate&#xD;
      depth of sedation, undergo their MRI. Monitoring during the MRI and subsequent recovery would&#xD;
      occur in compliance with the current Norton Children's Hospital Sedation policy.&#xD;
      Recovery-related behavior would be assessed using the Pediatric Anesthesia Emergence Delirium&#xD;
      Scale.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Unable to recruit the adequate number of subjects&#xD;
  </why_stopped>
  <start_date type="Actual">August 2014</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Number of Participants With Hypotension and/or Bradycardia During Sedation and Recovery (Generally 2-3 Hours)</measure>
    <time_frame>a total of 2-3 hours during sedation and recovery.</time_frame>
    <description>number of participants developing hypotension and or bradycardia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent Change in Heart Rate From Baseline</measure>
    <time_frame>during sedation and recovery (generally 2-3 hours)</time_frame>
    <description>Change in heart rate from baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Change in Blood Pressure From Baseline</measure>
    <time_frame>during sedation and recovery (generally 2-3 hours)</time_frame>
    <description>Change in blood pressure from baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Number of Participants With Adverse Recovery-related Behaviors During Sedation Recovery</measure>
    <time_frame>Recovery-related behaviors will be specifically measured using the &quot;Pediatric Anesthesia Emergence Delirium (PAED)&quot; scale every 5 minutes from procedure completion until sedation recovery is complete (usually less than 2 hrs)</time_frame>
    <description>This study will compare the number of participants with adverse recovery-related behaviors, based on the PAED scores, between the 2 treatment arms.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Sedation</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine and Ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will already be getting Dexmedetomidine and Ketamine for their routine care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine and Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will already be getting Dexmedetomidine and Midazolam for their routine care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Sedation medication</description>
    <arm_group_label>Dexmedetomidine and Ketamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Sedation medication</description>
    <arm_group_label>Dexmedetomidine and Midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Sedation medication</description>
    <arm_group_label>Dexmedetomidine and Ketamine</arm_group_label>
    <arm_group_label>Dexmedetomidine and Midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Inpatient at Kosair Children's Hospital.&#xD;
&#xD;
          2. Order placed by treating team for MRI of the brain with sedation.&#xD;
&#xD;
          3. Age less than or equal to 18 years.&#xD;
&#xD;
          4. Plan to sedate with dexmedetomidine, regardless of study participation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous adverse reaction to dexmedetomidine or clonidine&#xD;
&#xD;
          2. Current use of clonidine as a routine medication&#xD;
&#xD;
          3. Concurrent use of a heart-rate decreasing medication (digoxin, propranolol)&#xD;
&#xD;
          4. Contraindication to ketamine use&#xD;
&#xD;
               -  Intracranial hypertension or traumatic brain injury&#xD;
&#xD;
               -  Intraocular hypertension of eye trauma&#xD;
&#xD;
               -  Pulmonary hypertension requiring medical management&#xD;
&#xD;
          5. Planned additional procedure during the sedation encounter (non-brain MRI, lumbar&#xD;
             puncture, EEG etc)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John W. Berkenbosch, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 23, 2014</study_first_submitted>
  <study_first_submitted_qc>April 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2014</study_first_posted>
  <results_first_submitted>December 3, 2019</results_first_submitted>
  <results_first_submitted_qc>June 14, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">July 7, 2021</results_first_posted>
  <last_update_submitted>July 12, 2021</last_update_submitted>
  <last_update_submitted_qc>July 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>John W Berkenbosch</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Sedation</keyword>
  <keyword>MRI</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 2, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/26/NCT02129426/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Dexmedetomidine and Ketamine</title>
          <description>Subjects will already be getting Dexmedetomidine and Ketamine for their routine care.&#xD;
Ketamine&#xD;
Dexmedetomidine</description>
        </group>
        <group group_id="P2">
          <title>Dexmedetomidine and Midazolam</title>
          <description>Subjects will already be getting Dexmedetomidine and Midazolam for their routine care.&#xD;
Midazolam&#xD;
Dexmedetomidine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>21 subjects enrolled however, 1 subject's data was on paper archived and not available to perform demographic analysis therefore is not included here.</population>
      <group_list>
        <group group_id="B1">
          <title>Dexmedetomidine and Ketamine</title>
          <description>Subjects will already be getting Dexmedetomidine and Ketamine for their routine care.&#xD;
Ketamine&#xD;
Dexmedetomidine</description>
        </group>
        <group group_id="B2">
          <title>Dexmedetomidine and Midazolam</title>
          <description>Subjects will already be getting Dexmedetomidine and Midazolam for their routine care.&#xD;
Midazolam&#xD;
Dexmedetomidine</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <description>Collected: age and sex, weight, BMI, primary diagnosis, and reason for MRI race/ethnicity not collected per protocol</description>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27" spread="23"/>
                    <measurement group_id="B2" value="35" spread="18"/>
                    <measurement group_id="B3" value="32.2" spread="19.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <population>Race data was not collected.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kilogram per meter squared</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.4" spread="1.5"/>
                    <measurement group_id="B2" value="17.4" spread="2.6"/>
                    <measurement group_id="B3" value="17.0" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primary Diagnosis</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>seizure</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diplopia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ataxia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>syncope</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>MRI Indication</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Seizure</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diplopia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ataxia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Syncope</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Number of Participants With Hypotension and/or Bradycardia During Sedation and Recovery (Generally 2-3 Hours)</title>
        <description>number of participants developing hypotension and or bradycardia</description>
        <time_frame>a total of 2-3 hours during sedation and recovery.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine and Ketamine</title>
            <description>Subjects will already be getting Dexmedetomidine and Ketamine for their routine care.&#xD;
Ketamine&#xD;
Dexmedetomidine</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine and Midazolam</title>
            <description>Subjects will already be getting Dexmedetomidine and Midazolam for their routine care.&#xD;
Midazolam&#xD;
Dexmedetomidine</description>
          </group>
        </group_list>
        <measure>
          <title>The Number of Participants With Hypotension and/or Bradycardia During Sedation and Recovery (Generally 2-3 Hours)</title>
          <description>number of participants developing hypotension and or bradycardia</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hypotension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bradycardia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Change in Heart Rate From Baseline</title>
        <description>Change in heart rate from baseline.</description>
        <time_frame>during sedation and recovery (generally 2-3 hours)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine and Ketamine</title>
            <description>Subjects will already be getting Dexmedetomidine and Ketamine for their routine care.&#xD;
Ketamine&#xD;
Dexmedetomidine</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine and Midazolam</title>
            <description>Subjects will already be getting Dexmedetomidine and Midazolam for their routine care.&#xD;
Midazolam&#xD;
Dexmedetomidine</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Heart Rate From Baseline</title>
          <description>Change in heart rate from baseline.</description>
          <units>percent change from baseline</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-29.9" spread="7.5"/>
                    <measurement group_id="O2" value="-29.6" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>t-test comparison of the two groups</non_inferiority_desc>
            <p_value>0.96</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Change in Blood Pressure From Baseline</title>
        <description>Change in blood pressure from baseline.</description>
        <time_frame>during sedation and recovery (generally 2-3 hours)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine and Ketamine</title>
            <description>Subjects will already be getting Dexmedetomidine and Ketamine for their routine care.&#xD;
Ketamine&#xD;
Dexmedetomidine</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine and Midazolam</title>
            <description>Subjects will already be getting Dexmedetomidine and Midazolam for their routine care.&#xD;
Midazolam&#xD;
Dexmedetomidine</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change in Blood Pressure From Baseline</title>
          <description>Change in blood pressure from baseline.</description>
          <units>percent change from baseline</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-18.7" spread="12.2"/>
                    <measurement group_id="O2" value="-14.9" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.52</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Number of Participants With Adverse Recovery-related Behaviors During Sedation Recovery</title>
        <description>This study will compare the number of participants with adverse recovery-related behaviors, based on the PAED scores, between the 2 treatment arms.</description>
        <time_frame>Recovery-related behaviors will be specifically measured using the &quot;Pediatric Anesthesia Emergence Delirium (PAED)&quot; scale every 5 minutes from procedure completion until sedation recovery is complete (usually less than 2 hrs)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexmedetomidine and Ketamine</title>
            <description>Subjects will already be getting Dexmedetomidine and Ketamine for their routine care.&#xD;
Ketamine&#xD;
Dexmedetomidine</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine and Midazolam</title>
            <description>Subjects will already be getting Dexmedetomidine and Midazolam for their routine care.&#xD;
Midazolam&#xD;
Dexmedetomidine</description>
          </group>
        </group_list>
        <measure>
          <title>The Number of Participants With Adverse Recovery-related Behaviors During Sedation Recovery</title>
          <description>This study will compare the number of participants with adverse recovery-related behaviors, based on the PAED scores, between the 2 treatment arms.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Dexmedetomidine and Ketamine</title>
          <description>Subjects will already be getting Dexmedetomidine and Ketamine for their routine care.&#xD;
Ketamine&#xD;
Dexmedetomidine</description>
        </group>
        <group group_id="E2">
          <title>Dexmedetomidine and Midazolam</title>
          <description>Subjects will already be getting Dexmedetomidine and Midazolam for their routine care.&#xD;
Midazolam&#xD;
Dexmedetomidine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John W. Berkenbosch</name_or_title>
      <organization>University of Louisville</organization>
      <phone>502-852-3720</phone>
      <email>john.berkenbosch@louisville.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

